Strong sales and earnings increase in the first half-year 2023

Donaueschingen, 15 August 2023: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by approx. 12% and EBT by 23% in the first six months of 2023. As a result, the continually positive development of sales and earnings of the last years could be continued.

Sales improved from KEUR 100,032 to KEUR 111,842 (+11.8%) in the first half-year 2023. The international share of total business volume was 47.9% (6M-2022: 47.5%) and amounted to KEUR 53,516 compared to KEUR 47,488 (6M-2022).

The consolidated earnings before taxes (EBT) rose very sharply by 23.2% to KEUR 14,729 (6M-2022: KEUR 11,956), and consolidated surplus rose by 17.3% to KEUR 10,734 (6M-2022:
9,151 KEUR): EBIT increased by 12.0% from KEUR 12,403 (6M-2022) to KEUR 13,888, and EBITDA increased by 7.0% to KEUR 22,276 (6M-2022: KEUR 20,823).

Operating cash amounted to KEUR 25,460 in the first six months (6M-2022: KEUR 29,666) and remains at a very high level.

As of 30/06/2023, the company had cash resources at its disposal in the amount of KEUR 113,198 (31/12/2022: KEUR 110,019).

The half-year figures include sales from company acquisitions in the current year 2023 amounting to KEUR 798. The EBT was affected with TEUR 1,045.

Nexus AG had equity capital amounting to KEUR 245,180 as of 30/06/2023 (31/12/2022: KEUR 238,946). Consequently, the equity capital rate is 65.2% (31/12/2022: 69.4%).

This demonstrates that Nexus AG has a sustainable and healthy balance sheet as well as sufficient capital for further financing of its European growth strategy.